INCB018424 in Patients With Advanced Hematologic Malignancies

NCT00674479 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

51

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia
Acute Lymphocytic Leukemia
Myelodysplastic Syndrome
Chronic Myelogenous Leukemia

Interventions

DRUG: INCB018424

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]